These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 26430796)

  • 1. Stable Tricyclic Antitubercular Ozonides Derived from Artemisinin.
    Chaudhary S; Sharma V; Jaiswal PK; Gaikwad AN; Sinha SK; Puri SK; Sharon A; Maulik PR; Chaturvedi V
    Org Lett; 2015 Oct; 17(20):4948-51. PubMed ID: 26430796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Recent advances in the study of artemisinin-related 1,2,4-trioxanes and ozonides (1,2,4-trioxolanes) as antimalarials].
    Yang ZS; Li Y
    Yao Xue Xue Bao; 2005 Dec; 40(12):1057-63. PubMed ID: 16496665
    [No Abstract]   [Full Text] [Related]  

  • 3. Design, synthesis, and biological evaluation of dihydroartemisinin-fluoroquinolone conjugates as a novel type of potential antitubercular agents.
    Zhou FW; Lei HS; Fan L; Jiang L; Liu J; Peng XM; Xu XR; Chen L; Zhou CH; Zou YY; Liu CP; He ZQ; Yang DC
    Bioorg Med Chem Lett; 2014 Apr; 24(8):1912-7. PubMed ID: 24684842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conversion of antimalarial drug artemisinin to a new series of tricyclic 1,2,4-trioxanes1.
    Singh C; Chaudhary S; Kanchan R; Puri SK
    Org Lett; 2007 Oct; 9(21):4327-9. PubMed ID: 17877363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A small library of trisubstituted pyrimidines as antimalarial and antitubercular agents.
    Agarwal A; Srivastava K; Puri SK; Sinha S; Chauhan PM
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5218-21. PubMed ID: 16171994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient and stereocontrolled synthesis of 1,2,4-trioxolanes useful for ferrous iron-dependent drug delivery.
    Fontaine SD; DiPasquale AG; Renslo AR
    Org Lett; 2014 Nov; 16(21):5776-9. PubMed ID: 25331549
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary Evaluation of Artemisinin-Cholesterol Conjugates as Potential Drugs for the Treatment of Intractable Forms of Malaria and Tuberculosis.
    Morake M; Coertzen D; Ngwane A; Wentzel JF; Wong HN; Smit FJ; Birkholtz LM; Pietersen RD; Baker B; Wiid I; N'Da DD; Haynes RK
    ChemMedChem; 2018 Jan; 13(1):67-77. PubMed ID: 29193799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and efficacy of pyrvinium-inspired analogs against tuberculosis and malaria pathogens.
    Gaikwad VR; Karale UB; Govindarajalu G; Adhikari N; Krishna EV; Krishna VS; Misra S; Sriram D; Sijwali PS; Rode HB
    Bioorg Med Chem Lett; 2020 Apr; 30(8):127037. PubMed ID: 32081449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New N-arylamino biquinoline derivatives: synthesis, antimicrobial, antituberculosis, and antimalarial evaluation.
    Shah NM; Patel MP; Patel RG
    Eur J Med Chem; 2012 Aug; 54():239-47. PubMed ID: 22652224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review on various heterocyclic moieties and their antitubercular activity.
    Sharma S; Sharma PK; Kumar N; Dudhe R
    Biomed Pharmacother; 2011 Jul; 65(4):244-51. PubMed ID: 21715130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel indigoid anti-tuberculosis agent.
    Klein LL; Petukhova V; Wan B; Wang Y; Santasiero BD; Lankin DC; Pauli GF; Franzblau SG
    Bioorg Med Chem Lett; 2014 Jan; 24(1):268-70. PubMed ID: 24314672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design, synthesis of benzocoumarin-pyrimidine hybrids as novel class of antitubercular agents, their DNA cleavage and X-ray studies.
    Reddy DS; Hosamani KM; Devarajegowda HC
    Eur J Med Chem; 2015 Aug; 101():705-15. PubMed ID: 26210508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An atom economic synthesis and antitubercular evaluation of novel spiro-cyclohexanones.
    Ranjith Kumar R; Perumal S; Manju SC; Bhatt P; Yogeeswari P; Sriram D
    Bioorg Med Chem Lett; 2009 Jul; 19(13):3461-5. PubMed ID: 19473840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel 3-cyclohexylpropanoic acid-derived nitrogen heterocyclic compounds and their evaluation for tuberculostatic activity.
    Gobis K; Foks H; Bojanowski K; Augustynowicz-Kopeć E; Napiórkowska A
    Bioorg Med Chem; 2012 Jan; 20(1):137-44. PubMed ID: 22153872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A highly atom economic, chemo-, regio- and stereoselective synthesis and evaluation of spiro-pyrrolothiazoles as antitubercular agents.
    Karthikeyan SV; Bala BD; Raja VP; Perumal S; Yogeeswari P; Sriram D
    Bioorg Med Chem Lett; 2010 Jan; 20(1):350-3. PubMed ID: 19900810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the Exposure Time Dependence of the Activities of Synthetic Ozonide Antimalarials and Dihydroartemisinin against K13 Wild-Type and Mutant Plasmodium falciparum Strains.
    Yang T; Xie SC; Cao P; Giannangelo C; McCaw J; Creek DJ; Charman SA; Klonis N; Tilley L
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4501-10. PubMed ID: 27161632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ozonide Antimalarial Activity in the Context of Artemisinin-Resistant Malaria.
    Giannangelo C; Fowkes FJI; Simpson JA; Charman SA; Creek DJ
    Trends Parasitol; 2019 Jul; 35(7):529-543. PubMed ID: 31176584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and discovery of new bisadducts derived from heterocyclic aldehydes and active methylene compounds as potent antitubercular agents.
    Asad M; Oo CW; Kumar RS; Osman H; Ali MA
    Acta Pol Pharm; 2013; 70(2):221-8. PubMed ID: 23614277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, Biological Evaluation and Molecular Docking Studies of New Pyrazolines as an Antitubercular and Cytotoxic Agents.
    Lokesh BVS; Prasad YR; Shaik AB
    Infect Disord Drug Targets; 2019; 19(3):310-321. PubMed ID: 30556506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel 1,3,4-oxadiazoles as antitubercular agents with limited activity against drug-resistant tuberculosis.
    Makane VB; Krishna VS; Krishna EV; Shukla M; Mahizhaveni B; Misra S; Chopra S; Sriram D; Azger Dusthackeer VN; Rode HB
    Future Med Chem; 2019 Mar; 11(6):499-510. PubMed ID: 30892944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.